O
Ofi chem Netherlands 7G02
Ogene Systems India IP21
Omkar Speciality Chemicals India 10C79
Opocrin Italy 6G06
Orchid Chemicals & Pharmaceuticals India 10H36
Orffa Pharma Netherlands 7A53
Organica Feinchem Wolfen Germany 10J38
Orgentis Chemicals Germany 10J36
Orion Finland 4E55
Orofi no Pharmaceuticals Group Italy 10F23
Osmopharm Switzerland 10A60
PH&T Italy 10A50
Otsuka Chemical Europe Offi ce Spain 7A60
Pharma Action Germany 6H05
Otsuka Chemical India India 7A60
Pharma Waldhof Germany 5B06
Oystershell Belgium 7G44
Pharma Zentrale Germany 5A11
PharmaBioSource US 7A07
P Pharmaceutical Coatings India 7C09
PAB Organics India IP33 Pharmacore US USP092
Panreac Quimica Spain 10B15 Pharmacure Health Care Sweden 10H38
Parabolic Drugs India 10G42 Pharmadata Greece 10C24
Pars Ampoule Iran 10D36 PharmaMatch Netherlands 10C24
PCA - Prodotti Chimicie Alimentari Italy 3C22 Pharmascience Canada 3D06
PCAS France 4F60 Pharmasynthese France 6E22
Pen Tsao Chemical Industry Hong Kong 3E26 Pharmathen Greece 3F70
Pennakem US 5A30 PharmaZell Germany 3B50
Pentagon Chemical Specialties UK 7F70 Pharmexcil India IP12
PepTech US USP101 Phosphonic UK 7F70
Peptisyntha Belgium 5A06 PHT International US USP110
Perlen Converting Switzerland 6D22 Phytocos France 6E28
Peter Greven Fettchemie Germany 5A39 Pierre Fabre Medicament (Supercritical) France 6E28
Pfi zer Centresource US 4F24 Piramal Healthcare UK 5E06
23
Visit Fermion and Orion
at stand �E��
CRAMS@fermion
Fermion is a part of Orion Group, which is an innovative pharmaceutical
company in Finland. Originally Fermion was founded to develop products
manufactured through fermentation processes. Fermion with Orion
Corporation off ers Contract Research and Manufacturing Services to
our worldwide customer base.
Fermion has developed and manufactured the API for ten innovative
pharmaceutical products that have been commercialized worldwide or
Fermion is currently awaiting regulatory approval. ORION
Orion is an innovative European R&D-based
Fermion has two FDA-inspected plants with a capacity exceeding 320 m
3
pharmaceuticals and diagnostics company with an
and manufacture more than 220 tons of API per year. emphasis on developing medicinal treatments and
diagnostic tests for global markets. Orion develops,
Additional information: www.fermion.fi , CRAMS@orion.fi , manufactures and markets human and veterinary
fermionSales@orion.fi , fi rstname.lastname@orion.fi pharmaceuticals, APIs as well as diagnostic tests.
www.fermion.fi www.orion.fi
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44